colorado tirzepatide weight loss doctor Injections & Clinics Near You Medical Weight Loss Management |

Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis

Comparison of the beneficial effect of beta-blockers on mortality in patients with ischaemic and non-ischaemic heart failure

For people who are overweight or living with obesity and an autoimmune disease, this study offers a hopeful signal that medications already in use today may be beneficial in reducing their risk of cardiovascular disease. GLP-1 receptor agonists are commonly prescribed drugs to help patients with type 2 diabetes lose weight and manage their blood sugar levels

Key Allegations Against Novo Nordisk The crux of these lawsuits lies in allegations that Novo Nordisk, the manufacturer of Ozempic, was remiss in warning users about potential severe side effects, which include: Gastroparesis Concerns : Often termed stomach paralysis lawsuits, these claims assert that users were not adequately warned about the risk of delayed stomach emptying, a condition known as gastroparesis